231 related articles for article (PubMed ID: 12088343)
1. Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density.
Scariano JK; Garry PJ; Montoya GD; Duran-Valdez E; Baumgartner RN
Scand J Clin Lab Invest; 2002; 62(3):237-43. PubMed ID: 12088343
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN
Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men.
Chandani AK; Scariano JK; Glew RH; Clemens JD; Garry PJ; Baumgartner RN
Bone; 2000 May; 26(5):513-8. PubMed ID: 10773592
[TBL] [Abstract][Full Text] [Related]
4. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
5. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
7. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
8. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
Ageev FT; Barinova IV; Seredenina EM; Orlova IaA; Kuz'mina AE; Masenko VP; Kochetov AG
Kardiologiia; 2013; 53(6):51-8. PubMed ID: 23953046
[TBL] [Abstract][Full Text] [Related]
9. Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women.
Scariano JK; Garry PJ; Montoya GD; Wilson JM; Baumgartner RN
Clin Biochem; 2001 Nov; 34(8):639-44. PubMed ID: 11849624
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
11. A dual-label time-resolved fluorescence immunoassay for screening of osteoporosis based on simultaneous detection of C-terminal telopeptide (β-CTX) and aminoterminal propeptide (P1NP) of type I procollagen.
Xu Y; Wang Q; Hou G; Yao H; Zhao H
Scand J Clin Lab Invest; 2019; 79(1-2):80-85. PubMed ID: 30638079
[TBL] [Abstract][Full Text] [Related]
12. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers as predictors of rates of bone loss after menopause.
Rogers A; Hannon RA; Eastell R
J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
[TBL] [Abstract][Full Text] [Related]
14. Anthropometrics and biochemical markers in men.
Donescu OS; Battié MC; Videman T; Risteli J; Eyre D
J Clin Densitom; 2005; 8(2):222-7. PubMed ID: 15908711
[TBL] [Abstract][Full Text] [Related]
15. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.
Schneider DL; Barrett-Connor EL
Arch Intern Med; 1997 Jun; 157(11):1241-5. PubMed ID: 9183236
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
17. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
18. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
Thorsen K; Kristoffersson AO; Lorentzon RP
Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
[TBL] [Abstract][Full Text] [Related]
20. Analysis of daily teriparatide treatment for osteoporosis in men.
Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
Osteoporos Int; 2015 Apr; 26(4):1303-9. PubMed ID: 25567777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
